use
antimicrobi
widerang
differ
countri
countri
consum
human
medicin
veterinari
medicin
anim
farm
agricultur
us
quot
antibacteri
use
human
medicin
use
commun
hospit
suggest
prescrib
unnecessari
veterinari
farm
use
account
remain
therapeut
prophylact
growth
promot
purpos
usag
question
key
reduc
inappropri
use
antibacteri
develop
guidelin
prescrib
gener
maximum
health
gain
minimum
develop
resist
allianc
prudent
use
antibiot
apua
european
societi
clinic
microbiolog
infecti
diseas
escmid
author
made
recommend
work
partnership
context
act
steward
intern
level
also
nation
local
steward
sticht
werkgroep
antibioticabeleid
swab
netherland
swedish
strateg
programm
ration
use
antimicrobi
agent
surveil
resist
strama
us
equival
would
infecti
diseas
societi
america
idsa
center
communic
diseas
control
prevent
cdc
european
centr
diseas
prevent
control
ecdc
new
european
union
agenc
open
provid
stewardship
europ
infect
includ
influenza
sever
acut
respiratori
syndrom
sar
hiv
uk
clinician
follow
local
guidelin
refer
establish
refer
monthli
index
medic
specialti
mim
british
nation
formulari
bnf
dose
calcul
weight
age
children
standard
gener
use
otherwis
healthi
adult
prescrib
schedul
establish
popul
studi
tend
group
variabl
togeth
evid
target
organ
differ
minimum
inhibitori
concentr
pharmacokinet
drug
differ
differ
patient
result
unlucki
individu
infect
resist
organ
peak
concentr
area
curv
reduc
may
treatment
failur
result
subtherapeut
antibacteri
concentr
site
infect
extent
problem
contribut
global
problem
antimicrobi
resist
yet
establish
feel
like
highli
signific
select
resist
strain
use
antibacteri
outsid
standard
regimen
prescrib
longterm
lowdos
treatment
also
problemat
guillemot
carbon
show
convincingli
led
increas
likelihood
penicillinresist
pneumococci
emerg
children
hand
finish
cours
antibacteri
may
bad
thing
provid
relaps
infect
avoid
even
adequ
dosag
prolong
cours
breed
resist
therefor
tradit
advic
keep
take
tablet
longer
appropri
wish
develop
global
strategi
contain
antimicrobi
resist
sought
synthesi
recommend
expert
polici
group
approach
apua
recommend
base
follow
four
facet
establish
effect
surveil
system
assess
shift
antibacteri
resist
pattern
local
nation
global
scale
use
inform
guid
prescrib
appropri
use
antimicrobialsth
alter
patient
provid
behaviour
reduc
inappropri
use
antimicrobi
agentsto
encourag
research
develop
new
antimicrobi
agent
address
problem
establish
resist
organ
treat
infect
caus
surveil
indic
may
caus
futur
diseaseto
recognis
use
antibacteri
outsid
human
medicin
compar
quantiti
use
farm
industri
veterinari
practic
impact
human
health
assess
recommend
apua
antimicrobi
prescrib
influenc
follow
reduc
prescript
antibacteri
infect
bacteri
ie
viral
upper
respiratori
tract
infectionsreduc
overprescript
broadspectrum
antibacterialstighten
use
antibacteri
prophylact
situat
especi
respect
time
durationencourag
patient
complianc
prescript
includ
address
hoard
antibacteri
futur
usereview
use
antimicrobialcontain
cleaner
disinfectantspromot
use
nonantimicrobi
intervent
condom
bed
net
without
insecticid
impregn
vaccinationencourag
form
teach
like
result
modif
prescrib
behaviour
includ
interact
repeat
teach
session
workshop
problemsolv
sessionsus
audit
monitor
prescrib
behaviour
medicin
guidelin
produc
evid
base
apua
produc
comprehens
framework
follow
good
clinic
govern
evid
base
behind
recommend
may
confirm
randomis
clinic
trial
repres
synthesi
expert
opinion
common
sens
issu
antibacteri
drug
fear
perceiv
rather
real
health
risk
lead
clinician
overprescrib
broadspectrum
agent
instead
observ
clinic
develop
symptom
pend
result
bacteriolog
investig
nonbiomed
reason
overprescript
antibacteri
investig
lam
lam
found
public
sector
antibacteri
often
prescrib
timesav
measur
privat
sector
often
prescrib
fear
lose
client
summaris
relationship
use
antibacteri
develop
resist
human
ecosystem
live
problemat
current
prescrib
pattern
indic
problem
improv
good
control
stewardship
need
consid
chang
pattern
establish
improv
prescrib
pattern
improv
qualiti
use
reduc
resist
reduc
prescript
antibacteri
infect
bacteri
ie
viral
upper
respiratori
tract
infect
commun
initi
name
path
least
resist
advic
prescrib
antibacteri
sore
throat
cough
cold
limit
prescrib
uncompl
urinari
tract
infect
healthi
women
day
limit
telephon
prescrib
antibacteri
appear
effect
antibacteri
prescrib
rate
commun
fallen
england
million
script
per
year
million
largest
decreas
seen
prescript
children
broadspectrum
antibacteri
amoxicillinclavulan
acid
cefotaxim
tend
prescrib
patient
deem
septic
correct
inadequ
initi
therapi
compromis
patient
outcom
medic
surgic
ward
howev
fever
due
infect
infect
sever
assess
critic
patient
hospit
day
possibl
resist
bacteri
infect
consid
extendedspectrum
antibacteri
may
consid
patient
mrsa
recent
appear
septic
antibacteri
activ
mrsa
vancomycin
teicoplanin
linezolid
also
consid
reduc
overprescript
broadspectrum
antibacteri
hospit
set
close
liaison
microbiologist
clinician
regard
posit
cultur
ask
advic
aim
stop
narrow
spectrum
antibacteri
use
soon
investig
indic
appropri
treatment
may
whole
impact
intervent
substanti
could
poor
delay
commun
result
high
prescrib
rate
antibacteri
critic
ill
patient
intens
care
unit
icu
combin
ward
round
facilit
appropri
prescrib
uptod
result
may
yet
avail
comput
antibacteri
committe
compris
microbiologist
infecti
diseas
clinician
pharmacist
gener
list
restrict
antibacteri
prescrib
consult
establish
local
protocol
appropri
firstlin
antibacteri
given
clinic
scenario
target
like
pathogen
knowledg
local
sensit
pattern
antibacteri
formulari
review
period
anoth
approach
often
consid
mandatori
review
intraven
antibacteri
prescrib
hour
mainli
avoid
inappropri
long
cours
intraven
therapi
also
serv
prompt
review
posit
microbiolog
result
like
pathogen
isol
respons
clinician
rationalis
therapi
area
room
improv
problem
identifi
hospit
lead
inappropri
use
antibacteri
includ
insuffici
train
infecti
diseas
difficulti
select
appropri
antibacteri
empir
insuffici
use
microbiolog
inform
avail
fear
litig
also
major
antibacteri
prescrib
least
experienc
doctor
tighten
use
antibacteri
prophylaxi
reeduc
junior
surgeon
annual
basi
goe
way
toward
address
mean
control
problem
includ
inappropri
time
durat
administr
along
confus
appropri
agent
agent
use
scottish
intercollegi
guidelin
network
sign
guidelin
allow
input
local
data
assess
appropri
prophylaxi
local
situat
improv
patient
complianc
antibacteri
commun
patient
educ
commun
doctor
patient
must
improv
commun
skill
area
highlight
undergradu
postgradu
level
uk
last
year
introduct
roleplay
scenario
play
back
video
record
consult
multimedia
educ
campaign
carri
uk
twophas
campaign
first
phase
autumn
support
health
profession
manag
acut
upper
respiratori
tract
infect
reduc
patient
expect
prescript
encourag
use
symptomat
relief
second
promot
messag
antibacteri
kill
good
bacteria
keep
us
healthi
use
combin
press
magazin
media
relat
provid
resourc
pack
school
health
author
nonprescript
pad
gener
practition
hospit
apua
fifth
sixth
recommend
use
antimicrobialcontain
cleaner
nonantimicrobi
intervent
prescrib
address
recognis
didact
teach
work
well
problemsolv
workshop
modifi
prescrib
behaviour
studi
shown
antibacteri
workshop
led
reduct
prescrib
broadspectrum
antibacteri
commun
hospit
environ
especi
teach
hospit
conduc
ongo
learn
isol
doctor
perhap
gener
practic
might
easi
keep
date
howev
advent
websit
guidelin
even
dispar
unrealist
expect
doctor
date
thing
reason
keep
abreast
current
guidelin
drug
commonli
prescrib
includ
antibacteri
scottish
execut
british
societi
antimicrobi
chemotherapi
bsac
fund
websit
medic
undergradu
learn
prudent
prescrib
antibacteri
framework
learn
object
reflect
learn
webbas
format
call
appropri
antibiot
prescrib
tomorrow
doctor
apt
use
audit
monitor
prescrib
habit
success
databas
keep
record
antibacteri
prescrib
retrospect
analys
way
individu
depart
receiv
feedback
modifi
prescrib
habit
appropri
computeris
prescrib
allow
easier
audit
without
interf
prescrib
process
recent
europeanwid
audit
hospit
antibacteri
prescrib
access
http
wwwabdnacukarpac
ideal
world
everyon
bacteri
infect
requir
antibacteri
would
firm
microbiolog
diagnosi
narrowspectrum
antibacteri
commenc
minimum
durat
requir
cure
current
situat
degre
pragmat
requir
result
major
patient
receiv
appropri
antibacteri
therapi
give
indic
problem
clinic
relev
resist
pathogen
europ
use
inform
european
antimicrobi
resist
surveil
programm
earss
websit
http
wwwearssrivmnl
antibiot
resist
prevent
control
arpac
websit
http
wwwabdnacukarpac
earss
intern
network
nation
surveil
system
collect
compar
valid
antimicrobi
suscept
data
public
health
action
collect
inform
streptococcu
pneumonia
aureu
escherichia
coli
enterococcu
faecali
e
faecium
identifi
caus
invas
diseas
collect
data
laboratori
serv
hospit
countri
amass
data
isol
coordin
dutch
nation
institut
public
health
environ
rivm
earss
data
pneumonia
caus
invas
diseas
analys
assess
trend
resist
penicillin
erythromycin
overal
resist
penicillin
erythromycin
decreas
penicillin
resist
per
annum
increas
erythromycin
resist
per
annum
increas
dual
resist
per
annum
earss
predict
resist
erythromycin
dual
resist
arpac
deal
much
broader
select
resist
bacteria
specif
regard
hospit
infect
control
antibacteri
prescrib
infect
control
polici
incid
tuberculosi
uk
low
thank
highli
effect
nation
control
polici
patient
come
oversea
countri
origin
relev
may
like
multidrugresist
tuberculosi
situat
secondlin
agent
use
directli
observ
therapi
use
ensur
treatment
taken
greater
relev
undevelop
countri
peopl
may
less
inclin
complet
treatment
cours
start
feel
better
global
project
antituberculosi
treatmentresist
surveil
place
sinc
collabor
intern
union
tuberculosi
lung
diseas
partner
form
network
supran
laboratori
aid
nation
refer
laboratori
qualiti
assur
suscept
test
conjunct
nation
area
antituberculosi
treatmentresist
surveil
aim
project
estim
magnitud
pattern
antituberculosi
treatment
resist
monitor
trend
evalu
effect
treatment
programm
plan
evalu
intervent
prevent
programm
aid
develop
tuberculosi
polici
countri
level
strengthen
laboratori
servic
advoc
increas
polit
commit
identifi
research
need
commonli
prescrib
antivir
treatment
hiv
highli
activ
antiretrovir
therapi
haart
consist
two
nucleosid
revers
transcriptas
inhibitor
either
nonnucleosid
revers
transcriptas
inhibitor
one
two
proteas
inhibitor
british
hiv
associ
bhiva
produc
treatment
guidelin
possibl
carri
resist
test
patient
poor
complianc
tend
select
resist
virus
result
increas
viral
load
treatment
failur
along
increas
infect
resist
viru
increasingli
common
problem
global
hiv
treatmentresist
surveil
network
anoth
strategi
contain
antimicrobi
resist
treatment
tuberculosi
hiv
common
longer
durat
therapi
compar
infect
make
patient
complianc
control
advers
effect
import
major
morbid
mortal
develop
countri
children
year
old
die
lower
respiratori
tract
infect
malaria
bacillari
dysenteri
measl
well
malnutrit
signific
infecti
diseas
includ
hiv
tuberculosi
devis
integr
manag
childhood
ill
imci
syndrom
approach
clinic
manag
antimicrobi
use
would
depend
govern
polici
rang
antimicrobi
limit
laboratori
servic
somewhat
lack
govern
respons
ensur
knowledg
local
antimicrobi
sensit
pattern
avail
dissemin
district
medic
offic
dmo
nongovernment
agenc
work
area
liais
dmo
adher
nation
guidelin
importantli
must
ensur
medicin
still
efficaci
transport
given
climact
condit
temperatur
contain
expos
sun
may
rise
spoil
antibacteri
appear
counterfeit
drug
poor
qualiti
gener
avail
antibacteri
bought
counter
otc
ad
morbid
countri
counterfeit
gener
drug
may
less
efficaci
otc
antibiot
may
taken
short
time
low
dosag
expens
background
document
global
strategi
contain
antimicrobi
resist
call
drug
resist
malaria
conclud
peopl
need
access
antimalari
accept
lead
increas
level
resist
must
also
invest
control
measur
increas
use
lifespan
therapi
allow
time
new
treatment
control
develop
problem
prescrib
tuberculosi
complianc
therapi
feel
strongli
advis
commenc
treatment
supervis
full
durat
therapi
assur
usual
month
particular
relev
refuge
set
use
nonantimicrobi
intervent
mainli
target
malaria
bed
net
hiv
lowpric
condom
nation
vaccin
programm
incorpor
imci
dr
calvin
schwabe
talk
one
medicin
bring
togeth
human
veterinari
medicin
human
health
provid
mostlog
unifi
apic
caus
veterinari
medicin
hierarchi
valu
veterinarian
aspect
profess
opportun
respons
protect
health
wellb
peopl
includ
protect
food
secur
safeti
address
threat
antibiot
sensit
prevent
control
zoonot
emerg
infecti
diseas
protect
environ
ecosystem
particip
bio
agroterror
prepared
respons
use
skill
confront
nonzoonot
diseas
malaria
hivaid
vaccin
prevent
diseas
chronic
diseas
injuri
strengthen
publichealth
infrastructur
advanc
medic
scienc
research
veterinari
practic
use
equival
quantiti
antimicrobi
human
medicin
mainli
growth
promot
diseas
prevent
common
therapeut
use
includ
treat
mastiti
dairi
cattl
respiratori
ill
batteryrear
chicken
nontherapeut
use
includ
growth
promot
chicken
agricultur
streptomycin
oxytetracyclin
use
spray
fruit
orchard
make
visual
appeal
investig
situat
apua
initi
project
call
fact
antimicrobi
resist
anim
agricultur
impact
resist
faair
concern
overal
effect
antimicrobi
use
ecolog
point
view
two
way
consid
resist
infect
acquir
environ
first
direct
infect
human
pathogen
bacteria
salmonella
chicken
second
human
acquisit
resist
nonpathogen
bacteria
environ
act
reservoir
resist
gene
mayb
transfer
human
pathogen
bacteria
find
conclus
antimicrobi
use
select
resist
bacteri
strain
genet
vector
specifi
resist
gene
author
see
propag
antimicrobi
resist
ecolog
problem
suggest
reduc
would
requir
understand
commens
microbiota
mammal
genet
vector
resist
one
antimicrobi
select
resist
genet
linkag
resist
gene
antimicrobi
resist
emerg
period
use
antimicrobi
emerg
resist
vari
preval
reach
certain
level
revers
difficult
effect
global
problem
antimicrobi
resist
unknown
faair
conclus
antimicrobi
use
anywher
anyth
affect
anyon
anywher
world
cost
us
financi
health
may
affect
although
popul
level
cost
antibacteri
resist
known
therefor
elimin
nontherapeut
use
antimicrobi
food
anim
agricultur
benefit
us
european
commiss
ban
use
antibacteri
growth
promot
sever
group
look
way
evalu
safeti
ingest
antimicrobi
residu
use
veterinari
medicin
human
intestin
microflora
one
group
identifi
presenc
multidrugresist
enter
bacteria
dairi
farm
topsoil
implic
reservoir
bacteri
resist
clinic
relev
antibacteri
problem
resist
compound
handl
wast
food
anim
often
pollut
widespread
area
contamin
water
suppli
food
anim
may
also
develop
antibacterialresist
diseas
scale
problem
ascertain
mechan
increas
diseas
human
antimicrobi
resist
anim
multifactori
includ
increas
colonis
rate
increas
pathogen
decreas
efficaci
treatment
antimicrobi
uniqu
amongst
drug
use
result
reduc
efficaci
mani
area
room
improv
way
use
influenc
prescrib
medicin
prescriptiononli
impli
establish
infrastructur
healthcar
necessarili
exist
mani
develop
countri
inde
develop
countri
legisl
antimicrobi
prescriptiononli
human
medicin
farm
develop
counti
cultur
fear
microb
perhap
promot
product
kill
known
germ
dead
encourag
howev
tide
turn
peopl
becom
understand
germ
bad
fact
children
brought
hygien
rais
question
whether
increas
develop
allerg
condit
impair
immun
prescrib
attitud
cover
spectrum
conserv
aggress
use
antimicrobi
easili
justifi
lifethreaten
condit
often
prescrib
reduc
morbid
prevent
occasion
complic
word
doctor
deriv
greek
word
teacher
import
educ
patient
condit
fear
usual
result
ignor
reassur
address
problem
occur
recur
forgotten
develop
countri
influenc
prescrib
five
way
improv
diagnosi
sepsisaccess
latest
local
guidelin
subjectdecid
antimicrobi
treatment
withheld
pend
posit
microbiolog
decid
treatment
stop
rationalis
result
return
chase
result
receiv
timetreat
patient
result
advanc
inform
technolog
near
patient
test
could
also
improv
prescrib
behaviour
mani
develop
countri
need
improv
access
antimicrobi
prefer
control
environ
appropri
medic
advic
